US 8,545,514 B2Grant
Monorail neuro-microcatheter for delivery of medical devices to treat stroke, processes and products thereby
Issue Date:2013-10-01
•10 Claims
•5 Drawing Sheets
Abstract
Devices, processes and systems facilitate and enable treatment of acute stroke conditions, providing reperfusion while therapy is made available by preserving structure in the arterial tree. Using a Rapid Exchange approach with at least dual lumens in a microcatheter facilitates embolus/clot removal without damaging sensitive vasculature.
Metadata
Assignee
- Covidien LP
Inventor
- David A. Ferrera
Application Information
Application Number:US 12/422,105
Filing Date:2009-04-10
Priority Date:2008-04-11
Art Unit:3731
Classifications
IPC:
A61B17/221
Patent Drawings (5 sheets)
Description
Related Application
[0001] This application claims the benefit of and priority to U.S. Provisional Application Ser. No. 61/044,392, filed Apr. 11, 2008; U.S. Provisional Application Ser. No. 61/057,613, filed on May 30, 2008; U.S. Provisional Application Ser. No. 61/166,725, filed Apr. 4, 2009; the contents of which are incorporated by reference herein in their entirety.
Background of the Disclosure
[0002] This present disclosure relates to minimally invasive surgical devices, methods and systems. In particular, the present disclosure relates to systems designed to mitigate, extenuate or otherwise address acute stroke.
Summary of the Disclosure
[0003] Briefly stated, novel devices, improved processes and systems facilitate survival from, and preserve best options for, treatment of stroke.
[0004] According to embodiments there is disclosed a process for reperfusion during embolus removal comprising; providing a rapid exchange microcatheter system have at least two lumens, emplacing a microcatheter from the system within a blood vessel in the brain, accessing a desired treatment site, maintaining arterial access including greater support to the arterial tree, and addressing a subject embolus/blood clot.
[0005] According to embodiments, a process for making a neuro-monorail microcatheter includes at least one of co-extruding and skiving; co-extruding and skiving and lumen fillings; bonding tubes, and providing a predetermined microcatheter set, cutting a distal segment at 5-50 cm, aligning the same adjacent to a distal section of second microcatheter, placing guidewires in each microcatheter to maintain alignment, and applying short segments of PET along the length to secure and maintain alignment and adjacent status of the resulting device.
[0006] According to embodiments, a reperfusion device includes a rapid exchange system comprising a first lumen and a second lumen; a microcatheter disposed within the first lumen, comprising a stroke device, wherein the stroke device is expandable; and a guidewire disposed within the second lumen. The stroke device may comprise radiographic marking elements for visualization during placement, wherein the radiographic marking elements may be disposed at a distal end of the stroke device. The stroke device may be tethered, accessible, and retrievable through the microcatheter.
Brief Description of the Figures
[0007] The above-mentioned features and objects of the present disclosure will become more apparent with reference to the following description taken in conjunction with the accompanying drawings wherein like reference numerals denote like elements and in which:
[0008] FIG. 1 shows a schematic of an exemplary iteration of a device according to the present disclosure in a first position;
[0009] FIG. 2 shows a schematic of an exemplary iteration of a device according to the present disclosure in a second position;
[0010] FIG. 3 likewise schematically depicts an exemplary iteration of a device according to the present disclosure in a third position.
[0011] FIG. 4 illustrates a rapid exchange microcatheter in accordance with an embodiment of the invention.
Detailed Description of the Instant Teachings
[0012] The present inventors have discovered novel ways to treat strokes. This is done by providing microcatheter devices and therapy schemes whereby access is maintained during capture of emboli/thrombi/clot material without compromise to reperfusion of blood flow. The instant disclosures include microcatheters having at least second lumens for vessel stability during removal of emboli and/or in adjunct therapy modes, these devices are referred to as “Rapid Exchange” or RX systems.
[0013] The system of the instant disclosure allows and maintains arterial access to treatment sites, and provides enhanced support to the arterial tree, while working as a rapid exchange system. This enables secure capture of emboli/thrombi/clot material by providing support within the vessel. The RX support provided prevents the proximal vessel from buckling or kinking during tensioning upon embolus removal. This is a key feature, in that the literature is demonstrative of ovalizing, whereby stripping of the embolus from capture devices happens when buckling or kinking happens.
[0014] Expressly incorporated by reference as if fully set forth herein are U.S. Letters Patents and Publication Nos. 7,018,372; 6,893,417; and US 2007/0293846; US 2007/0293821; US 2007/0282306; US 2007/0276325; US 2007/0149949; US 2007/0197956.
[0015] The pathological course of a blood vessel that is blocked is a gradual progression from reversible ischemia to irreversible infarction (cell death). A stroke is often referred to as a “brain attack” and occurs when a blood vessel in the brain becomes blocked or ruptures. A ischemic stroke occurs when a blood vessel in the brain becomes blocked. Ischemic strokes comprise about 78% of all strokes. A hemorrhagic stroke, which account for the remaining 22% of strokes, occurs when a blood vessel in the brain ruptures. Stroke is the third leading cause of death in the United States, behind heart disease and cancer and is the leading cause of severe, longterm disability. Each year roughly 700,000 Americans experience a new or recurrent stroke. Stroke is the number one cause of inpatient Medicare reimbursement for long-term adult care. Total stroke costs now exceeds $45 billion per year in US healthcare dollars.
[0016] Currently there are only two FDA-approved mechanical treatment options for acute ischemic stroke. One option is a thrombo-embolectomy device. In August of 2004, Concentric Medical received FDA approval for its MERCI™ clot removal device. The Merci device is designed to capture an embolus or clot and remove it from the blocked vessel thereby restoring blood flow. The device is designed to be used in conjunction with a microcatheter. The microcatheter must cross the embolus before the Merci device can be deployed. The Merci device design is a cork-screwed guidewire. This device is only able to capture and remove matter that is firm or held together by itself. In most cases Merci breaks up the embolus rather than removes it and is used in combination with drug therapy to restore blood flow. A typical procedure using Merci will take 2-3 hours to restore blood flow if at all and may take multiple passes through the vessel to either capture, macerate or open the vessel. In some cases, the Merci device may capture an embolus but then lose grasp of it and deposit it incidentally in another area arc of the neuro vasculature creating a new stroke in a new territory. In some cases complications such as vessel dissection, perforation and hemorrhage arise as a result of manipulation in the vessel. Some issues in using Merci are that the Merci device itself is a guidewire. Therefore, once it is removed access is lost. Also, as the device is engaging an embolus and being withdrawn proximally, the vessels tend to be pulled with the device and buckle. This action appears to be a great source for the embolus fragmenting and vessel damage. A second option is an aspiration device manufactured by Penumbra, Inc. The embolus is removed by aspirating or sucking from the proximal side. A microwire is passed through the catheter into the embolus to aide in aspirating.
[0017] Several methods of treating stroke have been attempted, with varying degrees of success. However, according to the instant teachings, blood can be reperfused or emboli/thrombi/clot material can be removed from the neurovasculature consistently and safely with arterial support and access maintained during the procedure.
[0018] Other techniques used in addressing this issue comprise coextruded microcatheters having multi-lumen structures, as would be known to Artisans based on this disclosure and the claims appended hereto.
[0019] According embodiments of the present disclosure, an OTW system including a microcatheter having a delivery system tube is combined with a rapid exchange system as discussed above. The OTW system may be configured to fit within a lumen of the RX system. A microcatheter may be configured to fit within another lumen of the RX system. Examples of such a guidewire include Transend® or Synchro® brands. Examples of such a microcatheter include Cordis® MASSTRANSIT® or Renegade™ HI-FLO brands.
[0020] In some embodiments, the rapid exchange system comprises an RX microcatheter, a guidewire, a delivery device (e.g., wire or tube), and/or a therapeutic stroke device. In one embodiment, the RX microcatheter is a multi-lumen (e.g., dual-lumen) microcatheter. In one embodiment, the RX microcatheter has a proximal outer diameter of 3.0 F (0.039″) and a distal outer diameter of 3.5 F (0.045″). In one embodiment, a first lumen configured to receive a guidewire has a distal inner diameter of 0.017″ and the second lumen configured to receive the therapeutic stroke device has a distal inner diameter of 0.023″. In one embodiment, the guidewire is a 0.014″×190 cm wire.
[0021] The rapid exchange delivery catheter functions with, for example, CORDIS® brands of microcatheters available from them, and may be assembled as detailed below, or as known to those skilled in the art.
[0022] Referring now to FIG. 1 , according embodiments of the present disclosure, guidewire 99 accesses and crosses a target lesion, providing a pathway for RX microcatheter 101 having at least two lumens. Stroke device 103 is shown in a state of transition from a first (collapsed) position to a second (expanded) position emerging from a lumen of RX microcatheter 101. According to embodiments, guidewire 99 may be at least partially disposed within one of the two lumens of RX microcatheter 101.
[0023] Referring now to FIG. 2 , according embodiments of the present disclosure, stroke device 103 includes radiographic marking elements 105 for visualization during placement. Likewise, those skilled in the art readily accomplished using the system of the present invention.
[0024] Referring now also to FIG. 3 , according embodiments of the present disclosure, stroke device 103 is shown in a fully expanded position, whereby it functions consistently and safely such that arterial support is maintained in virtue of guidewire 99 keeping the arterial tree from mechanical stress, while embolus removal, clot capture and other procedures are done. Thus, reperfusion is established and therapy administered without risks to patients present with other devices. According to embodiments, as shown in FIG. 3 , stroke device 103 may be tethered such that, while emplaced at a treatment site within a blood vessel, it remains accessible via a microcatheter and readily retrievable therein while maintaining reperfusion of the blood vessel. In one embodiment, the stroke device is tethered to the delivery device via tethered lines. According to embodiments, stroke device 103 may be emplaced on a long-term or permanent basis, or as needed based on the amount and type of recanalization prescribed. According to embodiments, stroke device 103 is self-expandable, such that is may expand substantially radially when removed from within the catheter. According to embodiments, additional therapies may be provided while stroke device 103 is fully expanded, for example, through another lumen of RX microcatheter 101.
[0025] According to embodiments of the present disclosure, a process for making a neuro-monorail microcatheter is disclosed. The process may include cutting a first microcatheter at a distal end. A segment may be cut at about 5 cm to 50 cm from a distal end of the microcatheter. The segment of the first catheter may be aligned adjacent to a distal section of a second microcatheter. Guidewires may be placed in each of first and second microcatheters to maintain their respective alignments and keep their lumens open. A resin, such as Polyethylene terephthalate (PET), may be applied in short segments along the lengths of the first and second microcatheters to secure and maintain alignment and adjacent status of the finished device.
[0026] According to embodiments of the present disclosure, a first and second catheter, as described above, may be co-extruded and skived, in lieu of the cutting discussed above, and joined as discussed above. In one embodiment, the segment of the neuro-monorail microcatheter configured to receive a guidewire can have a length of about 35 cm to about 40 cm. In one embodiment, the segment of the neuro-monorail microcatheter configured to receive a guidewire can extend 35 cm from the distal end of the neuro-monorail microcatheter.
[0027] FIG. 4 illustrates a rapid exchange microcatheter 401 in accordance with an embodiment of the invention. The rapid exchange microcatheter 401 includes a first lumen and a second lumen. The second lumen is within a rapid exchange segment 402 of the rapid exchange microcatheter 401 having a length L. As shown, the guidewire 99 can be inserted within the second lumen of the rapid exchange segment 402. The length L of the rapid exchange segment 402 (and the second lumen within) can range from about 5 cm to 50 cm. In some embodiments, the length L can range from about 35 cm to about 40 cm to provide support within the cerebral vasculature (for example, to facilitate movement of the guidewire within tortuous regions of the cerebral vasculature or to prevent buckling or kinking of vessels of the cerebral vasculature).
[0028] While the method and agent have been described in terms of what are presently considered to be the most practical and preferred embodiments, it is to be understood that the disclosure need not be limited to the disclosed embodiments. It is intended to cover various modifications and similar arrangements included within the spirit and scope of the claims, the scope of which should be accorded the broadest interpretation so as to encompass all such modifications and similar structures. The present disclosure includes any and all embodiments of the following claims.
[0029] It should also be understood that a variety of changes may be made without departing from the essence of the invention. Such changes are also implicitly included in the description. They still fall within the scope of this invention. It should be understood that this disclosure is intended to yield a patent covering numerous aspects of the invention both independently and as an overall system and in both method and apparatus modes.
[0030] Further, each of the various elements of the invention and claims may also be achieved in a variety of manners. This disclosure should be understood to encompass each such variation, be it a variation of an embodiment of any apparatus embodiment, a method or process embodiment, or even merely a variation of any element of these.
[0031] Particularly, it should be understood that as the disclosure relates to elements of the invention, the words for each element may be expressed by equivalent apparatus terms or method terms—even if only the function or result is the same.
[0032] Such equivalent, broader, or even more generic terms should be considered to be encompassed in the description of each element or action. Such terms can be substituted where desired to make explicit the implicitly broad coverage to which this invention is entitled.
[0033] It should be understood that all actions may be expressed as a means for taking that action or as an element which causes that action.
[0034] Similarly, each physical element disclosed should be understood to encompass a disclosure of the action which that physical element facilitates.
[0035] Any patents, publications, or other references mentioned in this application for patent are hereby incorporated by reference. In addition, as to each term used it should be understood that unless its utilization in this application is inconsistent with such interpretation, common dictionary definitions should be understood as incorporated for each term and all definitions, alternative terms, and synonyms such as contained in at least one of a standard technical dictionary recognized by artisans and the Random House Webster's Unabridged Dictionary, latest edition are hereby incorporated by reference.
[0036] Finally, all referenced listed in the Information Disclosure Statement or other information statement filed with the application are hereby appended and hereby incorporated by reference; however, as to each of the above, to the extent that such information or statements incorporated by reference might be considered inconsistent with the patenting of this/these invention(s), such statements are expressly not to be considered as made by the applicant(s).
[0037] In this regard it should be understood that for practical reasons and so as to avoid adding potentially hundreds of claims, the applicant has presented claims with initial dependencies only.
[0038] Support should be understood to exist to the degree required under new matter laws—including but not limited to United States Patent Law 35 USC 132 or other such laws—to permit the addition of any of the various dependencies or other elements presented under one independent claim or concept as dependencies or elements under any other independent claim or concept.
[0039] To the extent that insubstantial substitutes are made, to the extent that the applicant did not in fact draft any claim so as to literally encompass any particular embodiment, and to the extent otherwise applicable, the applicant should not be understood to have in any way intended to or actually relinquished such coverage as the applicant simply may not have been able to anticipate all eventualities; one skilled in the art, should not be reasonably expected to have drafted a claim that would have literally encompassed such alternative embodiments.
[0040] Further, the use of the transitional phrase “comprising” is used to maintain the “open-end” claims herein, according to traditional claim interpretation. Thus, unless the context requires otherwise, it should be understood that the term “comprise” or variations such as “comprises” or “comprising”, are intended to imply the inclusion of a stated element or step or group of elements or steps but not the exclusion of any other element or step or group of elements or steps.
[0041] Such terms should be interpreted in their most expansive forms so as to afford the applicant the broadest coverage legally permissible.
Claims
The invention claimed is:
1. A dual lumen reperfusion system for insertion into cerebral vasculature for the treatment of ischemic stroke, comprising, in combination:
a rapid exchange microcatheter comprising a proximal end, a distal end, a first lumen, and a second lumen separate from the first lumen, both the first lumen and the second lumen terminating distally at the distal end of the rapid exchange microcatheter, the first lumen terminating proximally at the proximal end of the rapid exchange microcatheter;
wherein the rapid exchange microcatheter is dimensioned for delivery in tortuous cerebral vasculature;
a delivery device disposed within the first lumen;
wherein the delivery device is coupled to a stroke device, wherein the stroke device is self-expandable;
wherein the stroke device is configured to facilitate reperfusion and removal of one or more stroke-inducing emboli within a blood vessel in the brain;
a guidewire disposed within the second lumen; and
wherein the second lumen is housed by a segment of the rapid exchange microcatheter that has a length that is less than an entire length of the rapid exchange microcatheter and in the range of about 5 cm to about 50 cm to facilitate movement of the guidewire through the tortuous cerebral vasculature.
2. The reperfusion system of claim 1, wherein the stroke device comprises radiographic marking elements for visualization during placement.
3. The reperfusion system of claim 2, wherein the radiographic marking elements are disposed at a distal end of the stroke device.
4. The reperfusion system of claim 1, wherein the stroke device is tethered to the delivery device and accessible through the microcatheter.
5. The reperfusion system of claim 1, wherein the stroke device is retrievable through the microcatheter.
6. The reperfusion system of claim 1, wherein the second lumen is housed by a segment of the microcatheter that has a length of about 35 cm to about 40 cm.
7. A dual lumen reperfusion system for insertion into cerebral vasculature for the treatment of ischemic stroke, comprising:
a rapid exchange microcatheter comprising a proximal end, a distal end, a first lumen, and a second lumen separate from the first lumen, the first lumen extending from the distal end to the proximal end, and the second lumen extending from the distal end to a location between the proximal end and the distal end;
a delivery device disposed within the first lumen, comprising a stroke device, wherein the stroke device is expandable; and
a guidewire disposed within the second lumen;
wherein the second lumen is housed by a segment of the rapid exchange microcatheter that has a length in the range of about 35 cm to about 40 cm to provide support within the cerebral vasculature.
8. The reperfusion system of claim 7, wherein the stroke device is coupled to the delivery device via tethered lines.
9. A reperfusion system for insertion into cerebral vasculature for the treatment of ischemic stroke, comprising:
a rapid exchange microcatheter comprising a first catheter and a second catheter, the first catheter having a first length and defining a first lumen extending the first length, the second catheter having a second length and defining a second lumen extending the second length, the first length being greater than the second length, the second catheter extending adjacent to a distal section of the first catheter with a distal end of the second catheter aligned with a distal end of the first catheter;
a delivery device disposed within the first lumen, comprising a stroke device, wherein the stroke device is expandable; and
a guidewire disposed within the second lumen.
10. The reperfusion system of claim 9, wherein the first catheter and the second catheter are co-extruded.
Patent Citations (591)
| Patent | Date | Inventor | Cited By |
|---|---|---|---|
| US2709999(A) | 1955-06-01 | Nagel | Applicant |
| US3174851(A) | 1965-03-01 | Buehler et al. | Applicant |
| US3351463(A) | 1967-11-01 | Rozner et al. | Applicant |
| US3506171(A) | 1970-04-01 | Rupert | Applicant |
| US3753700(A) | 1973-08-01 | Harrison et al. | Applicant |
| US4650466(A) | 1987-03-01 | Luther | Applicant |
| US4993481(A) | 1991-02-01 | Kamimoto et al. | Applicant |
| US4998539(A) | 1991-03-01 | Delsanti | Applicant |
| US5035686(A) | 1991-07-01 | Crittenden et al. | Applicant |
| US5057114(A) | 1991-10-01 | Wittich et al. | Applicant |
| US5222964(A) | 1993-06-01 | Cooper | Applicant |
| US5222971(A) | 1993-06-01 | Willard et al. | Applicant |
| US5275622(A) | 1994-01-01 | Lazarus et al. | Applicant |
| US5327885(A) | 1994-07-01 | Griffith | Applicant |
| US5344395(A) | 1994-09-01 | Whalen | Applicant |
| US5370653(A) | 1994-12-01 | Cragg | Applicant |
| US5425739(A) | 1995-06-01 | Jessen | Applicant |
| US5449372(A) | 1995-09-01 | Schmaltz | Applicant |
| US5456667(A) | 1995-10-01 | Ham et al. | Applicant |
| US5527282(A) | 1996-06-01 | Segal | Applicant |
| US5643309(A) | 1997-07-01 | Myler et al. | Applicant |
| US5649906(A) | 1997-07-01 | Gory et al. | Applicant |
| US5653743(A) | 1997-08-01 | Martin | Applicant |
| US5681336(A) | 1997-10-01 | Clement et al. | Applicant |
| US5683449(A) | 1997-11-01 | Marcade | Applicant |
| US5695469(A) | 1997-12-01 | Segal | Applicant |
| US5718724(A) | 1998-02-01 | Goicoechea et al. | Applicant |
| US5792157(A) | 1998-08-01 | Mische et al. | Applicant |
| US5795322(A) | 1998-08-01 | Boudewijn | Applicant |
| US5800457(A) | 1998-09-01 | Gelbfish | Applicant |
| US5800519(A) | 1998-09-01 | Sandock | Applicant |
| US5827324(A) | 1998-10-01 | Cassell et al. | Applicant |
| US5853419(A) | 1998-12-01 | Imran | Applicant |
| US5916235(A) | 1999-06-01 | Guglielmi | Applicant |
| US5922019(A) | 1999-07-01 | Hankh et al. | Applicant |
| US5928260(A) | 1999-07-01 | Chin | Applicant |
| US5938671(A) | 1999-08-01 | Katoh | Applicant |
| US5938697(A) | 1999-08-01 | Killion et al. | Applicant |
| US5941895(A) | 1999-08-01 | Myler et al. | Applicant |
| US5947995(A) | 1999-09-01 | Samuels | Applicant |
| US5951599(A) | 1999-09-01 | McCrory | Applicant |
| US5961547(A) | 1999-10-01 | Razavi | Applicant |
| US5968013(A) | 1999-10-01 | Smith et al. | Applicant |
| US5972016(A) | 1999-10-01 | Morales | Applicant |
| US5972019(A) | 1999-10-01 | Engelson | Applicant |
| US5972219(A) | 1999-10-01 | Habets | Applicant |
| US5976120(A) | 1999-11-01 | Chow et al. | Applicant |
| US5980514(A) | 1999-11-01 | Kupiecki et al. | Applicant |
| US6001118(A) | 1999-12-01 | Daniel et al. | Applicant |
| US6010449(A) | 2000-01-01 | Selmon et al. | Applicant |
| US6010498(A) | 2000-01-01 | Guglielmi | Applicant |
| US6010521(A) | 2000-01-01 | Lee et al. | Applicant |
| US6015424(A) | 2000-01-01 | Rosenbluth et al. | Applicant |
| US6039721(A) | 2000-03-01 | Johnson | Applicant |
| US6051020(A) | 2000-04-01 | Goicoechea et al. | Applicant |
| US6063070(A) | 2000-05-01 | Eder | Applicant |
| US6063104(A) | 2000-05-01 | Villar et al. | Applicant |
| US6063111(A) | 2000-05-01 | Hieshima et al. | Applicant |
| US6066149(A) | 2000-05-01 | Samson et al. | Applicant |
| US6066158(A) | 2000-05-01 | Engelson | Applicant |
| US6093199(A) | 2000-07-01 | Brown et al. | Applicant |
| US6096034(A) | 2000-08-01 | Kupiecki et al. | Applicant |
| US6106548(A) | 2000-08-01 | Roubin et al. | Applicant |
| US6117167(A) | 2000-09-01 | Goicoechea et al. | Applicant |
| US6123115(A) | 2000-09-01 | Greenhalgh | Applicant |
| US6136006(A) | 2000-10-01 | Johnson et al. | Applicant |
| US6146396(A) | 2000-11-01 | Konya et al. | Applicant |
| US6159238(A) | 2000-12-01 | Killion et al. | Applicant |
| US6159239(A) | 2000-12-01 | Greenhalgh | Applicant |
| US6164339(A) | 2000-12-01 | Greenhalgh | Applicant |
| US6168592(B1) | 2001-01-01 | Kupiecki et al. | Applicant |
| US6168604(B1) | 2001-01-01 | Cano | Applicant |
| US6190358(B1) | 2001-02-01 | Fitzmaurice | Applicant |
| US6192944(B1) | 2001-02-01 | Greenhalgh | Applicant |
| US6193708(B1) | 2001-02-01 | Ken et al. | Applicant |
| US6210364(B1) | 2001-04-01 | Anderson | Applicant |
| US6217609(B1) | 2001-04-01 | Haverkost | Applicant |
| US6221096(B1) | 2001-04-01 | Aiba et al. | Applicant |
| US6231598(B1) | 2001-05-01 | Berry et al. | Applicant |
| US6238430(B1) | 2001-05-01 | Klumb et al. | Applicant |
| US6280413(B1) | 2001-08-01 | Clark et al. | Applicant |
| US6283940(B1) | 2001-09-01 | Mullholland | Applicant |
| US6283992(B1) | 2001-09-01 | Hankh et al. | Applicant |
| US6290720(B1) | 2001-09-01 | Khosravi et al. | Applicant |
| US6302906(B1) | 2001-10-01 | Goicoechea et al. | Applicant |
| US6305436(B1) | 2001-10-01 | Andersen et al. | Applicant |
| US6306141(B1) | 2001-10-01 | Jervis | Applicant |
| US6322585(B1) | 2001-11-01 | Khosravi et al. | Applicant |
| US6325815(B1) | 2001-12-01 | Kusleika et al. | Applicant |
| US6325820(B1) | 2001-12-01 | Khosravi et al. | Applicant |
| US6325822(B1) | 2001-12-01 | Chouinard et al. | Applicant |
| US6344041(B1) | 2002-02-01 | Kupiecki et al. | Applicant |
| US6383205(B1) | 2002-05-01 | Samson et al. | Applicant |
| US6390993(B1) | 2002-05-01 | Cornish et al. | Applicant |
| US6402771(B1) | 2002-06-01 | Palmer et al. | Applicant |
| US6454780(B1) | 2002-09-01 | Wallace | Applicant |
| US6458139(B1) | 2002-10-01 | Palmer et al. | Applicant |
| US6468301(B1) | 2002-10-01 | Amplatz et al. | Applicant |
| US6475236(B1) | 2002-11-01 | Roubin et al. | Applicant |
| US6475237(B2) | 2002-11-01 | Drasler et al. | Applicant |
| US6485500(B1) | 2002-11-01 | Kokish | Applicant |
| US6485509(B2) | 2002-11-01 | Killion et al. | Applicant |
| US6537294(B1) | 2003-03-01 | Boyle et al. | Examiner |
| US6551341(B2) | 2003-04-01 | Boylan et al. | Applicant |
| US6551342(B1) | 2003-04-01 | Shen et al. | Applicant |
| US6553810(B2) | 2003-04-01 | Webb et al. | Applicant |
| US6554856(B1) | 2003-04-01 | Doorly et al. | Applicant |
| US6558405(B1) | 2003-05-01 | McInnes | Applicant |
| US6562066(B1) | 2003-05-01 | Martin | Applicant |
| US6569179(B2) | 2003-05-01 | Teoh et al. | Applicant |
| US6569193(B1) | 2003-05-01 | Cox et al. | Applicant |
| US6575997(B1) | 2003-06-01 | Palmer et al. | Applicant |
| US6589265(B1) | 2003-07-01 | Palmer et al. | Applicant |
| US6592607(B1) | 2003-07-01 | Palmer et al. | Examiner |
| US6592615(B1) | 2003-07-01 | Marcade et al. | Applicant |
| US6605057(B2) | 2003-08-01 | Fitzmaurice | Applicant |
| US6610077(B1) | 2003-08-01 | Hancock et al. | Applicant |
| US6616617(B1) | 2003-09-01 | Ferrera et al. | Applicant |
| US6629953(B1) | 2003-10-01 | Boyd | Applicant |
| US6632241(B1) | 2003-10-01 | Hancock et al. | Applicant |
| US6635081(B2) | 2003-10-01 | Khosravi et al. | Applicant |
| US6638294(B1) | 2003-10-01 | Palmer | Applicant |
| US6641590(B1) | 2003-11-01 | Palmer et al. | Applicant |
| US6652505(B1) | 2003-11-01 | Tsugita | Applicant |
| US6652576(B1) | 2003-11-01 | Stalker | Applicant |
| US6660021(B1) | 2003-12-01 | Palmer et al. | Applicant |
| US6663607(B2) | 2003-12-01 | Slaikeu et al. | Applicant |
| US6666829(B2) | 2003-12-01 | Cornish et al. | Applicant |
| US6669723(B2) | 2003-12-01 | Killion et al. | Applicant |
| US6673025(B1) | 2004-01-01 | Richardson et al. | Applicant |
| US6685722(B1) | 2004-02-01 | Rosenbluth | Applicant |
| US6685738(B2) | 2004-02-01 | Chouinard et al. | Applicant |
| US6695813(B1) | 2004-02-01 | Boyle et al. | Applicant |
| US6702843(B1) | 2004-03-01 | Brown et al. | Applicant |
| US6709440(B2) | 2004-03-01 | Callol et al. | Applicant |
| US6716178(B1) | 2004-04-01 | Kilpatrick et al. | Applicant |
| US6723112(B2) | 2004-04-01 | Ho et al. | Applicant |
| US6730104(B1) | 2004-05-01 | Sepetka et al. | Applicant |
| US6733519(B2) | 2004-05-01 | Lashinski | Applicant |
| US6746468(B1) | 2004-06-01 | Sepetka et al. | Applicant |
| US6764506(B2) | 2004-07-01 | Roubin et al. | Applicant |
| US6773454(B2) | 2004-08-01 | Wholey et al. | Applicant |
| US6790237(B2) | 2004-09-01 | Stinson | Applicant |
| US6795979(B2) | 2004-09-01 | Fournier | Applicant |
| US6802851(B2) | 2004-10-01 | Jones et al. | Applicant |
| US6818015(B2) | 2004-11-01 | Hankh et al. | Applicant |
| US6821291(B2) | 2004-11-01 | Bolea et al. | Applicant |
| US6824558(B2) | 2004-11-01 | Parodi | Applicant |
| US6833003(B2) | 2004-12-01 | Jones et al. | Applicant |
| US6840958(B2) | 2005-01-01 | Nunez et al. | Applicant |
| US6881220(B2) | 2005-04-01 | Edwin et al. | Applicant |
| US6893413(B2) | 2005-05-01 | Martin | Applicant |
| US6913612(B2) | 2005-07-01 | Palmer et al. | Applicant |
| US6949620(B2) | 2005-09-01 | Aida et al. | Applicant |
| US6953472(B2) | 2005-10-01 | Palmer et al. | Applicant |
| US6955685(B2) | 2005-10-01 | Escamilla et al. | Applicant |
| US6960227(B2) | 2005-11-01 | Jones et al. | Applicant |
| US6991641(B2) | 2006-01-01 | Diaz et al. | Applicant |
| US6994723(B1) | 2006-02-01 | McMahon | Applicant |
| US7001422(B2) | 2006-02-01 | Escamilla et al. | Applicant |
| US7004954(B1) | 2006-02-01 | Voss | Applicant |
| US7004955(B2) | 2006-02-01 | Shen et al. | Applicant |
| US7004956(B2) | 2006-02-01 | Palmer et al. | Applicant |
| US7018401(B1) | 2006-03-01 | Hyodoh et al. | Applicant |
| US7029688(B2) | 2006-04-01 | Hubbell et al. | Applicant |
| US7037329(B2) | 2006-05-01 | Martin | Applicant |
| US7041116(B2) | 2006-05-01 | Goto et al. | Applicant |
| US7048014(B2) | 2006-05-01 | Hyodoh et al. | Applicant |
| US7056328(B2) | 2006-06-01 | Arnott | Applicant |
| US7056336(B2) | 2006-06-01 | Armstrong et al. | Applicant |
| US7060091(B2) | 2006-06-01 | Killion et al. | Applicant |
| US7089218(B1) | 2006-08-01 | Visel | Applicant |
| US7112217(B1) | 2006-09-01 | Kugler et al. | Applicant |
| US7118600(B2) | 2006-10-01 | Dua et al. | Applicant |
| US7125419(B2) | 2006-10-01 | Sequin et al. | Applicant |
| US7128736(B1) | 2006-10-01 | Abrams et al. | Applicant |
| US7144421(B2) | 2006-12-01 | Carpenter et al. | Applicant |
| US7147655(B2) | 2006-12-01 | Chermoni | Applicant |
| US7147660(B2) | 2006-12-01 | Chobotov et al. | Applicant |
| US7156869(B1) | 2007-01-01 | Pacetti | Applicant |
| US7160317(B2) | 2007-01-01 | McHale | Applicant |
| US7169165(B2) | 2007-01-01 | Belef et al. | Applicant |
| US7172575(B2) | 2007-02-01 | El-Nounou | Applicant |
| US7172617(B2) | 2007-02-01 | Colgan et al. | Applicant |
| US7175607(B2) | 2007-02-01 | Lim | Applicant |
| US7179273(B1) | 2007-02-01 | Palmer et al. | Applicant |
| US7179284(B2) | 2007-02-01 | Khosravi et al. | Applicant |
| US7201769(B2) | 2007-04-01 | Jones et al. | Applicant |
| US7201770(B2) | 2007-04-01 | Johnson | Applicant |
| US7223284(B2) | 2007-05-01 | Khosravi et al. | Applicant |
| US7238197(B2) | 2007-07-01 | Sequin et al. | Applicant |
| US7240516(B2) | 2007-07-01 | Pryor | Applicant |
| US7241301(B2) | 2007-07-01 | Thramann et al. | Applicant |
| US7279003(B2) | 2007-10-01 | Berra et al. | Applicant |
| US7279292(B2) | 2007-10-01 | Imam et al. | Applicant |
| US7285126(B2) | 2007-10-01 | Sepetka et al. | Applicant |
| US7294147(B2) | 2007-11-01 | Hartley | Applicant |
| US7300458(B2) | 2007-11-01 | Henkes et al. | Applicant |
| US7306619(B1) | 2007-12-01 | Palmer | Applicant |
| US7309345(B2) | 2007-12-01 | Wallace | Applicant |
| US7309351(B2) | 2007-12-01 | Escamilla | Applicant |
| US7323000(B2) | 2008-01-01 | Monstdt et al. | Applicant |
| US7323005(B2) | 2008-01-01 | Wallace et al. | Applicant |
| US7323006(B2) | 2008-01-01 | Andreas et al. | Applicant |
| US7326240(B1) | 2008-02-01 | Caro et al. | Applicant |
| US7344550(B2) | 2008-03-01 | Carrison et al. | Applicant |
| US7344556(B2) | 2008-03-01 | Sequin et al. | Applicant |
| US7351255(B2) | 2008-04-01 | Andreas | Applicant |
| US7354455(B2) | 2008-04-01 | Stinson | Applicant |
| US7402169(B2) | 2008-07-01 | Killion et al. | Applicant |
| US7407509(B2) | 2008-08-01 | Greenberg et al. | Applicant |
| US7435254(B2) | 2008-10-01 | Chouinard et al. | Applicant |
| US7438720(B2) | 2008-10-01 | Shaked | Applicant |
| US7455646(B2) | 2008-11-01 | Richardson et al. | Applicant |
| US7473272(B2) | 2009-01-01 | Pryor | Applicant |
| US7494474(B2) | 2009-02-01 | Richardson et al. | Applicant |
| US7549974(B2) | 2009-06-01 | Nayak | Applicant |
| US7691122(B2) | 2010-04-01 | Dieck et al. | Applicant |
| US7727242(B2) | 2010-06-01 | Sepetka et al. | Applicant |
| US7727243(B2) | 2010-06-01 | Sepetka et al. | Applicant |
| US7749243(B2) | 2010-07-01 | Phung | Applicant |
| US7780694(B2) | 2010-08-01 | Palmer et al. | Applicant |
| US7833240(B2) | 2010-11-01 | Okushi et al. | Applicant |
| US7972342(B2) | 2011-07-01 | Gandhi et al. | Applicant |
| US8052640(B2) | 2011-11-01 | Fiorella et al. | Applicant |
| US8062307(B2) | 2011-11-01 | Sepetka et al. | Applicant |
| US8066757(B2) | 2011-11-01 | Ferrera et al. | Applicant |
| US8070791(B2) | 2011-12-01 | Ferrera et al. | Applicant |
| US8088140(B2) | 2012-01-01 | Ferrera et al. | Applicant |
| US8100918(B2) | 2012-01-01 | Gandhi et al. | Applicant |
| US8100935(B2) | 2012-01-01 | Rosenbluth et al. | Applicant |
| US8105333(B2) | 2012-01-01 | Sepetka et al. | Applicant |
| US8197493(B2) | 2012-06-01 | Ferrera et al. | Applicant |
| US2001/0000797(A1) | 2001-05-01 | Mazzocchi | Applicant |
| US2001/0004705(A1) | 2001-06-01 | Killion et al. | Applicant |
| US2001/0010013(A1) | 2001-07-01 | Cox et al. | Applicant |
| US2001/0031981(A1) | 2001-10-01 | Evans et al. | Applicant |
| US2001/0034531(A1) | 2001-10-01 | Ho et al. | Applicant |
| US2001/0044633(A1) | 2001-11-01 | Klint | Applicant |
| US2001/0044647(A1) | 2001-11-01 | Pinchuk et al. | Applicant |
| US2001/0047202(A1) | 2001-11-01 | Slaikeu et al. | Applicant |
| US2001/0051823(A1) | 2001-12-01 | Khosravi et al. | Applicant |
| US2002/0004681(A1) | 2002-01-01 | Teoh et al. | Applicant |
| US2002/0007210(A1) | 2002-01-01 | Chouinard et al. | Applicant |
| US2002/0016564(A1) | 2002-02-01 | Courtney et al. | Applicant |
| US2002/0016624(A1) | 2002-02-01 | Patterson | Applicant |
| US2002/0032479(A1) | 2002-03-01 | Hankh et al. | Applicant |
| US2002/0038142(A1) | 2002-03-01 | Khosravi et al. | Applicant |
| US2002/0038146(A1) | 2002-03-01 | Harry | Applicant |
| US2002/0052643(A1) | 2002-05-01 | Wholey et al. | Applicant |
| US2002/0068968(A1) | 2002-06-01 | Hupp | Applicant |
| US2002/0072790(A1) | 2002-06-01 | McGuckin, Jr. et al. | Applicant |
| US2002/0087209(A1) | 2002-07-01 | Edwin et al. | Applicant |
| US2002/0091355(A1) | 2002-07-01 | Hayden | Applicant |
| US2002/0095141(A1) | 2002-07-01 | Belef | Applicant |
| US2002/0143387(A1) | 2002-10-01 | Soetikno et al. | Applicant |
| US2002/0161377(A1) | 2002-10-01 | Rabkin | Applicant |
| US2002/0169458(A1) | 2002-11-01 | Connors | Applicant |
| US2002/0183831(A1) | 2002-12-01 | Rolando et al. | Applicant |
| US2002/0198588(A1) | 2002-12-01 | Armstrong et al. | Applicant |
| US2003/0004536(A1) | 2003-01-01 | Boylan et al. | Applicant |
| US2003/0023230(A1) | 2003-01-01 | Lewis et al. | Applicant |
| US2003/0023299(A1) | 2003-01-01 | Amplatz et al. | Applicant |
| US2003/0032941(A1) | 2003-02-01 | Boyle et al. | Applicant |
| US2003/0032977(A1) | 2003-02-01 | Brady | Applicant |
| US2003/0040771(A1) | 2003-02-01 | Hyodoh et al. | Applicant |
| US2003/0040772(A1) | 2003-02-01 | Hyodoh et al. | Applicant |
| US2003/0055440(A1) | 2003-03-01 | Jones et al. | Applicant |
| US2003/0055451(A1) | 2003-03-01 | Jones et al. | Applicant |
| US2003/0074056(A1) | 2003-04-01 | Killion et al. | Applicant |
| US2003/0078605(A1) | 2003-04-01 | Bashiri et al. | Applicant |
| US2003/0097114(A1) | 2003-05-01 | Ouriel et al. | Applicant |
| US2003/0105484(A1) | 2003-06-01 | Boyle | Applicant |
| US2003/0125791(A1) | 2003-07-01 | Sequin et al. | Applicant |
| US2003/0125798(A1) | 2003-07-01 | Martin | Applicant |
| US2003/0130719(A1) | 2003-07-01 | Martin | Applicant |
| US2003/0139796(A1) | 2003-07-01 | Sequin et al. | Applicant |
| US2003/0139803(A1) | 2003-07-01 | Sequin et al. | Applicant |
| US2003/0149475(A1) | 2003-08-01 | Hyodoh et al. | Applicant |
| US2003/0153944(A1) | 2003-08-01 | Phung et al. | Applicant |
| US2003/0176914(A1) | 2003-09-01 | Rabkin et al. | Applicant |
| US2003/0199921(A1) | 2003-10-01 | Palmer et al. | Applicant |
| US2003/0204202(A1) | 2003-10-01 | Palmer et al. | Applicant |
| US2004/0002752(A1) | 2004-01-01 | Griffin et al. | Applicant |
| US2004/0006306(A1) | 2004-01-01 | Evans et al. | Applicant |
| US2004/0006381(A1) | 2004-01-01 | Sequin et al. | Applicant |
| US2004/0019322(A1) | 2004-01-01 | Hoffmann | Applicant |
| US2004/0030378(A1) | 2004-02-01 | Khosravi et al. | Applicant |
| US2004/0034386(A1) | 2004-02-01 | Fulton et al. | Applicant |
| US2004/0049258(A1) | 2004-03-01 | Khosravi et al. | Applicant |
| US2004/0054367(A1) | 2004-03-01 | Jimenez, Jr. et al. | Applicant |
| US2004/0059259(A1) | 2004-03-01 | Cornish et al. | Applicant |
| US2004/0059407(A1) | 2004-03-01 | Escamilla et al. | Applicant |
| US2004/0068288(A1) | 2004-04-01 | Palmer et al. | Applicant |
| US2004/0073300(A1) | 2004-04-01 | Chouinard et al. | Applicant |
| US2004/0078071(A1) | 2004-04-01 | Escamilla et al. | Applicant |
| US2004/0079429(A1) | 2004-04-01 | Miller et al. | Applicant |
| US2004/0088002(A1) | 2004-05-01 | Boyle et al. | Applicant |
| US2004/0102838(A1) | 2004-05-01 | Killion et al. | Applicant |
| US2004/0106979(A1) | 2004-06-01 | Goicoechea et al. | Applicant |
| US2004/0114912(A1) | 2004-06-01 | Okamoto et al. | Applicant |
| US2004/0117003(A1) | 2004-06-01 | Ouriel et al. | Applicant |
| US2004/0147939(A1) | 2004-07-01 | Rabkin et al. | Applicant |
| US2004/0158307(A1) | 2004-08-01 | Jones et al. | Applicant |
| US2004/0158312(A1) | 2004-08-01 | Chouinard et al. | Applicant |
| US2004/0186562(A1) | 2004-09-01 | Cox | Applicant |
| US2004/0193246(A1) | 2004-09-01 | Ferrera | Applicant |
| US2004/0199201(A1) | 2004-10-01 | Kellett et al. | Applicant |
| US2004/0215312(A1) | 2004-10-01 | Andreas | Applicant |
| US2004/0215319(A1) | 2004-10-01 | Berra et al. | Applicant |
| US2004/0249439(A1) | 2004-12-01 | Richter et al. | Applicant |
| US2004/0254628(A1) | 2004-12-01 | Nazzaro et al. | Applicant |
| US2004/0260385(A1) | 2004-12-01 | Jones et al. | Applicant |
| US2005/0033334(A1) | 2005-02-01 | Santra et al. | Applicant |
| US2005/0033349(A1) | 2005-02-01 | Jones et al. | Applicant |
| US2005/0033409(A1) | 2005-02-01 | Burke et al. | Applicant |
| US2005/0038447(A1) | 2005-02-01 | Huffmaster | Applicant |
| US2005/0038468(A1) | 2005-02-01 | Panetta et al. | Applicant |
| US2005/0038496(A1) | 2005-02-01 | Jones et al. | Applicant |
| US2005/0049676(A1) | 2005-03-01 | Nazzaro et al. | Applicant |
| US2005/0060017(A1) | 2005-03-01 | Fischell et al. | Applicant |
| US2005/0075715(A1) | 2005-04-01 | Borges et al. | Applicant |
| US2005/0080480(A1) | 2005-04-01 | Bolea et al. | Applicant |
| US2005/0090857(A1) | 2005-04-01 | Kusleika et al. | Applicant |
| US2005/0096726(A1) | 2005-05-01 | Sequin et al. | Applicant |
| US2005/0102018(A1) | 2005-05-01 | Carpenter et al. | Applicant |
| US2005/0107823(A1) | 2005-05-01 | Leone et al. | Applicant |
| US2005/0119684(A1) | 2005-06-01 | Guterman | Applicant |
| US2005/0125023(A1) | 2005-06-01 | Bates | Applicant |
| US2005/0126979(A1) | 2005-06-01 | Lowe | Applicant |
| US2005/0131515(A1) | 2005-06-01 | Cully et al. | Applicant |
| US2005/0131516(A1) | 2005-06-01 | Greenhalgh | Applicant |
| US2005/0159774(A1) | 2005-07-01 | Belef | Applicant |
| US2005/0177228(A1) | 2005-08-01 | Solem et al. | Applicant |
| US2005/0187612(A1) | 2005-08-01 | Edwin | Applicant |
| US2005/0192661(A1) | 2005-09-01 | Griffen et al. | Applicant |
| US2005/0209673(A1) | 2005-09-01 | Shaked | Applicant |
| US2005/0209675(A1) | 2005-09-01 | Ton et al. | Applicant |
| US2005/0209678(A1) | 2005-09-01 | Henkes et al. | Applicant |
| US2005/0216050(A1) | 2005-09-01 | Sepetka et al. | Applicant |
| US2005/0222583(A1) | 2005-10-01 | Cano | Applicant |
| US2005/0222607(A1) | 2005-10-01 | Palmer et al. | Applicant |
| US2005/0267570(A1) | 2005-12-01 | Shadduck | Applicant |
| US2005/0277978(A1) | 2005-12-01 | Greenhalgh | Applicant |
| US2006/0020285(A1) | 2006-01-01 | Niermann | Applicant |
| US2006/0020321(A1) | 2006-01-01 | Parker | Applicant |
| US2006/0025845(A1) | 2006-02-01 | Escamilla et al. | Applicant |
| US2006/0025850(A1) | 2006-02-01 | Feller et al. | Applicant |
| US2006/0030865(A1) | 2006-02-01 | Balg | Applicant |
| US2006/0036281(A1) | 2006-02-01 | Patterson | Applicant |
| US2006/0052816(A1) | 2006-03-01 | Bates et al. | Applicant |
| US2006/0058833(A1) | 2006-03-01 | VanCamp | Applicant |
| US2006/0058836(A1) | 2006-03-01 | Bose et al. | Applicant |
| US2006/0058838(A1) | 2006-03-01 | Bose et al. | Applicant |
| US2006/0074480(A1) | 2006-04-01 | Bales et al. | Applicant |
| US2006/0089703(A1) | 2006-04-01 | Escamilla et al. | Applicant |
| US2006/0100663(A1) | 2006-05-01 | Palmer et al. | Applicant |
| US2006/0106421(A1) | 2006-05-01 | Teoh | Applicant |
| US2006/0106448(A1) | 2006-05-01 | Shaked | Applicant |
| US2006/0122685(A1) | 2006-06-01 | Bonsignore et al. | Applicant |
| US2006/0135947(A1) | 2006-06-01 | Soltesz et al. | Applicant |
| US2006/0142841(A1) | 2006-06-01 | Khosravi et al. | Applicant |
| US2006/0142849(A1) | 2006-06-01 | Killion et al. | Applicant |
| US2006/0195172(A1) | 2006-08-01 | Luo et al. | Applicant |
| US2006/0200048(A1) | 2006-09-01 | Furst et al. | Applicant |
| US2006/0200221(A1) | 2006-09-01 | Malewicz | Applicant |
| US2006/0224180(A1) | 2006-10-01 | Anderson et al. | Applicant |
| US2006/0229645(A1) | 2006-10-01 | Bonnette et al. | Applicant |
| US2006/0259119(A1) | 2006-11-01 | Rucker | Applicant |
| US2006/0265054(A1) | 2006-11-01 | Greenhalgh et al. | Applicant |
| US2006/0271090(A1) | 2006-11-01 | Shaked et al. | Applicant |
| US2006/0276883(A1) | 2006-12-01 | Greenberg et al. | Applicant |
| US2006/0287701(A1) | 2006-12-01 | Pal | Applicant |
| US2006/0287704(A1) | 2006-12-01 | Hartley et al. | Applicant |
| US2007/0032852(A1) | 2007-02-01 | Machek et al. | Applicant |
| US2007/0043424(A1) | 2007-02-01 | Pryor | Applicant |
| US2007/0043425(A1) | 2007-02-01 | Hartley et al. | Applicant |
| US2007/0055299(A1) | 2007-03-01 | Ishimaru et al. | Applicant |
| US2007/0055358(A1) | 2007-03-01 | Krolik et al. | Applicant |
| US2007/0055360(A1) | 2007-03-01 | Hanson et al. | Applicant |
| US2007/0055365(A1) | 2007-03-01 | Greenberg et al. | Applicant |
| US2007/0067011(A1) | 2007-03-01 | Krolik et al. | Applicant |
| US2007/0073376(A1) | 2007-03-01 | Krolik et al. | Applicant |
| US2007/0088387(A1) | 2007-04-01 | Eskridge et al. | Applicant |
| US2007/0100425(A1) | 2007-05-01 | Sequin et al. | Applicant |
| US2007/0118205(A1) | 2007-05-01 | Davidson et al. | Applicant |
| US2007/0123972(A1) | 2007-05-01 | Greenberg et al. | Applicant |
| US2007/0135888(A1) | 2007-06-01 | Khosravi et al. | Applicant |
| US2007/0141036(A1) | 2007-06-01 | Gorrochategui Barrueta et al. | Applicant |
| US2007/0142896(A1) | 2007-06-01 | Anderson et al. | Applicant |
| US2007/0156170(A1) | 2007-07-01 | Hancock et al. | Applicant |
| US2007/0156228(A1) | 2007-07-01 | Majercak et al. | Applicant |
| US2007/0162109(A1) | 2007-07-01 | Davila et al. | Applicant |
| US2007/0191866(A1) | 2007-08-01 | Palmer et al. | Applicant |
| US2007/0191884(A1) | 2007-08-01 | Eskridge et al. | Applicant |
| US2007/0191924(A1) | 2007-08-01 | Rudakov | Applicant |
| US2007/0198028(A1) | 2007-08-01 | Miloslavski | Applicant |
| US2007/0198030(A1) | 2007-08-01 | Martin et al. | Applicant |
| US2007/0198075(A1) | 2007-08-01 | Levy | Applicant |
| US2007/0203452(A1) | 2007-08-01 | Mehta | Applicant |
| US2007/0203559(A1) | 2007-08-01 | Freudenthal et al. | Applicant |
| US2007/0208367(A1) | 2007-09-01 | Fiorella | Applicant |
| US2007/0208371(A1) | 2007-09-01 | French et al. | Applicant |
| US2007/0219621(A1) | 2007-09-01 | Hartley et al. | Applicant |
| US2007/0225794(A1) | 2007-09-01 | Thramann et al. | Applicant |
| US2007/0233236(A1) | 2007-10-01 | Pryor | Applicant |
| US2007/0250040(A1) | 2007-10-01 | Provost et al. | Applicant |
| US2007/0266542(A1) | 2007-11-01 | Melsheimer | Applicant |
| US2007/0270932(A1) | 2007-11-01 | Headley et al. | Applicant |
| US2007/0288034(A1) | 2007-12-01 | MacCollum et al. | Applicant |
| US2007/0288037(A1) | 2007-12-01 | Cheng et al. | Applicant |
| US2007/0288080(A1) | 2007-12-01 | Maccollum et al. | Applicant |
| US2007/0288083(A1) | 2007-12-01 | Hines | Applicant |
| US2007/0293846(A1) | 2007-12-01 | von Oepen et al. | Applicant |
| US2007/0299503(A1) | 2007-12-01 | Berra et al. | Applicant |
| US2008/0001333(A1) | 2008-01-01 | Kleine et al. | Applicant |
| US2008/0015558(A1) | 2008-01-01 | Harlan | Applicant |
| US2008/0015682(A1) | 2008-01-01 | Majercak et al. | Applicant |
| US2008/0033528(A1) | 2008-02-01 | Satasiya et al. | Applicant |
| US2008/0039926(A1) | 2008-02-01 | Majercak et al. | Applicant |
| US2008/0039930(A1) | 2008-02-01 | Jones et al. | Applicant |
| US2008/0045995(A1) | 2008-02-01 | Guterman et al. | Applicant |
| US2008/0046064(A1) | 2008-02-01 | Sequin et al. | Applicant |
| US2008/0046072(A1) | 2008-02-01 | Laborde et al. | Applicant |
| US2008/0051803(A1) | 2008-02-01 | Monjtadt | Applicant |
| US2008/0058724(A1) | 2008-03-01 | Wallace et al. | Applicant |
| US2008/0071178(A1) | 2008-03-01 | Greenland et al. | Applicant |
| US2008/0077175(A1) | 2008-03-01 | Palmer | Applicant |
| US2008/0082159(A1) | 2008-04-01 | Tseng et al. | Applicant |
| US2008/0086196(A1) | 2008-04-01 | Truckai et al. | Applicant |
| US2008/0097495(A1) | 2008-04-01 | Feller et al. | Applicant |
| US2008/0103477(A1) | 2008-05-01 | Jones | Applicant |
| US2008/0103585(A1) | 2008-05-01 | Monstadt | Applicant |
| US2008/0109063(A1) | 2008-05-01 | Hancock et al. | Applicant |
| US2008/0109067(A1) | 2008-05-01 | Caro et al. | Applicant |
| US2008/0114445(A1) | 2008-05-01 | Melsheimer et al. | Applicant |
| US2008/0125855(A1) | 2008-05-01 | Henkes et al. | Applicant |
| US2008/0140107(A1) | 2008-06-01 | Bei et al. | Applicant |
| US2008/0140181(A1) | 2008-06-01 | Reynolds et al. | Applicant |
| US2008/0147100(A1) | 2008-06-01 | Wallace et al. | Applicant |
| US2008/0161903(A1) | 2008-07-01 | Sequin et al. | Applicant |
| US2008/0161936(A1) | 2008-07-01 | Feller et al. | Applicant |
| US2008/0167708(A1) | 2008-07-01 | Molland et al. | Applicant |
| US2008/0195140(A1) | 2008-08-01 | Myla et al. | Applicant |
| US2008/0200946(A1) | 2008-08-01 | Braun et al. | Applicant |
| US2008/0208319(A1) | 2008-08-01 | Rabkin et al. | Applicant |
| US2008/0221554(A1) | 2008-09-01 | O'Connor et al. | Applicant |
| US2008/0221600(A1) | 2008-09-01 | Dieck et al. | Applicant |
| US2008/0221664(A1) | 2008-09-01 | Bales et al. | Applicant |
| US2008/0221671(A1) | 2008-09-01 | Chouinard et al. | Applicant |
| US2008/0228216(A1) | 2008-09-01 | Strauss et al. | Applicant |
| US2008/0234795(A1) | 2008-09-01 | Snow et al. | Applicant |
| US2008/0243229(A1) | 2008-10-01 | Wallace et al. | Applicant |
| US2008/0243232(A1) | 2008-10-01 | Hegg et al. | Applicant |
| US2008/0247943(A1) | 2008-10-01 | Lanza et al. | Applicant |
| US2008/0249598(A1) | 2008-10-01 | Sherry | Applicant |
| US2008/0255678(A1) | 2008-10-01 | Cully et al. | Applicant |
| US2008/0262506(A1) | 2008-10-01 | Griffin et al. | Applicant |
| US2008/0262528(A1) | 2008-10-01 | Martin | Applicant |
| US2008/0262532(A1) | 2008-10-01 | Martin | Applicant |
| US2008/0262592(A1) | 2008-10-01 | Jordan et al. | Applicant |
| US2008/0262952(A1) | 2008-10-01 | Channell | Applicant |
| US2008/0269774(A1) | 2008-10-01 | Garcia et al. | Applicant |
| US2008/0269868(A1) | 2008-10-01 | Bei et al. | Applicant |
| US2008/0275497(A1) | 2008-11-01 | Palmer et al. | Applicant |
| US2008/0275498(A1) | 2008-11-01 | Palmer et al. | Applicant |
| US2008/0275536(A1) | 2008-11-01 | Zarins et al. | Applicant |
| US2008/0281302(A1) | 2008-11-01 | Murphy et al. | Applicant |
| US2008/0281350(A1) | 2008-11-01 | Sepetka et al. | Applicant |
| US2008/0281393(A1) | 2008-11-01 | Armstrong et al. | Applicant |
| US2008/0281397(A1) | 2008-11-01 | Killion et al. | Applicant |
| US2008/0281403(A1) | 2008-11-01 | Kavteladze | Applicant |
| US2008/0306503(A1) | 2008-12-01 | Que et al. | Applicant |
| US2008/0306504(A1) | 2008-12-01 | Win et al. | Applicant |
| US2008/0312732(A1) | 2008-12-01 | Hartley et al. | Applicant |
| US2008/0319525(A1) | 2008-12-01 | Tieu et al. | Applicant |
| US2008/0319533(A1) | 2008-12-01 | Lehe | Applicant |
| US2009/0018633(A1) | 2009-01-01 | Lindquist et al. | Applicant |
| US2009/0018634(A1) | 2009-01-01 | State | Applicant |
| US2009/0018640(A1) | 2009-01-01 | State | Applicant |
| US2009/0024157(A1) | 2009-01-01 | Anukhin | Applicant |
| US2009/0025820(A1) | 2009-01-01 | Adams | Applicant |
| US2009/0030502(A1) | 2009-01-01 | Sun et al. | Applicant |
| US2009/0036968(A1) | 2009-02-01 | Hepworth et al. | Applicant |
| US2009/0036977(A1) | 2009-02-01 | Rassat et al. | Applicant |
| US2009/0062726(A1) | 2009-03-01 | Ford et al. | Applicant |
| US2009/0062773(A1) | 2009-03-01 | Cornish et al. | Applicant |
| US2009/0062834(A1) | 2009-03-01 | Moftakhar et al. | Applicant |
| US2009/0068097(A1) | 2009-03-01 | Sevrain | Applicant |
| US2009/0069828(A1) | 2009-03-01 | Martin et al. | Applicant |
| US2009/0069836(A1) | 2009-03-01 | Labdag et al. | Applicant |
| US2009/0076450(A1) | 2009-03-01 | Caizza et al. | Applicant |
| US2009/0082800(A1) | 2009-03-01 | Janardhan | Applicant |
| US2009/0093822(A1) | 2009-04-01 | Ducharme | Applicant |
| US2009/0105644(A1) | 2009-04-01 | Leonard et al. | Applicant |
| US2009/0105722(A1) | 2009-04-01 | Fulkerson | Applicant |
| US2009/0105737(A1) | 2009-04-01 | Fulkerson | Applicant |
| US2009/0105747(A1) | 2009-04-01 | Chanduszko et al. | Applicant |
| US2009/0125053(A1) | 2009-05-01 | Ferrera et al. | Applicant |
| US2009/0192455(A1) | 2009-07-01 | Ferrera et al. | Applicant |
| US2009/0292297(A1) | 2009-11-01 | Ferrera | Applicant |
| US2009/0299393(A1) | 2009-12-01 | Martin et al. | Applicant |
| US2010/0022951(A1) | 2010-01-01 | Ferrera et al. | Applicant |
| US2010/0114017(A1) | 2010-05-01 | Lenker et al. | Applicant |
| US2010/0114135(A1) | 2010-05-01 | Wilson et al. | Applicant |
| US2010/0137892(A1) | 2010-06-01 | Krolik et al. | Applicant |
| US2010/0152766(A1) | 2010-06-01 | Dieck et al. | Applicant |
| US2010/0174309(A1) | 2010-07-01 | Fulkerson et al. | Applicant |
| US2010/0217187(A1) | 2010-08-01 | Fulkerson et al. | Applicant |
| US2010/0256600(A1) | 2010-10-01 | Ferrera | Applicant |
| US2010/0318097(A1) | 2010-12-01 | Ferrera et al. | Applicant |
| US2011/0009875(A1) | 2011-01-01 | Grandfield et al. | Applicant |
| US2011/0009941(A1) | 2011-01-01 | Grandfield et al. | Applicant |
| US2011/0060212(A1) | 2011-03-01 | Slee et al. | Applicant |
| US2011/0152920(A1) | 2011-06-01 | Eckhouse et al. | Applicant |
| US2011/0160742(A1) | 2011-06-01 | Ferrera et al. | Applicant |
| US2011/0160757(A1) | 2011-06-01 | Ferrera et al. | Applicant |
| US2011/0160760(A1) | 2011-06-01 | Ferrera et al. | Applicant |
| US2011/0160761(A1) | 2011-06-01 | Ferrera et al. | Applicant |
| US2011/0160763(A1) | 2011-06-01 | Ferrera et al. | Applicant |
| US2011/0166586(A1) | 2011-07-01 | Sepetka et al. | Applicant |
| US2011/0172699(A1) | 2011-07-01 | Miller et al. | Applicant |
| US2011/0184456(A1) | 2011-07-01 | Grandfield et al. | Applicant |
| US2011/0190797(A1) | 2011-08-01 | Fulkerson et al. | Applicant |
| US2011/0202088(A1) | 2011-08-01 | Eckhouse et al. | Applicant |
| US2011/0238106(A1) | 2011-09-01 | Ferrera et al. | Applicant |
| US2011/0270178(A1) | 2011-11-01 | Fiorella et al. | Applicant |
| US2011/0288572(A1) | 2011-11-01 | Martin | Applicant |
| US2011/0301686(A1) | 2011-12-01 | Bowman et al. | Applicant |
| US2011/0319917(A1) | 2011-12-01 | Ferrera et al. | Applicant |
| US2012/0016396(A1) | 2012-01-01 | Dehnad | Applicant |
| US2012/0016406(A1) | 2012-01-01 | Ferrera et al. | Applicant |
| US2012/0022576(A1) | 2012-01-01 | Ferrera et al. | Applicant |
| US2012/0022581(A1) | 2012-01-01 | Wilson et al. | Applicant |
| US2012/0035648(A1) | 2012-02-01 | Wilson et al. | Applicant |
| US2012/0041411(A1) | 2012-02-01 | Horton et al. | Applicant |
| US2012/0041449(A1) | 2012-02-01 | Eckhouse et al. | Applicant |
| US2012/0041459(A1) | 2012-02-01 | Fiorella et al. | Applicant |
| US2012/0041460(A1) | 2012-02-01 | Ferrera et al. | Applicant |
| US2012/0041464(A1) | 2012-02-01 | Monetti et al. | Applicant |
| US2012/0041474(A1) | 2012-02-01 | Eckhouse et al. | Applicant |
| US2012/0041475(A1) | 2012-02-01 | Ferrera et al. | Applicant |
| US2012/0046686(A1) | 2012-02-01 | Wilson et al. | Applicant |
| US2012/0065660(A1) | 2012-03-01 | Ferrera et al. | Applicant |
| US2012/0071964(A1) | 2012-03-01 | Cattaneo et al. | Applicant |
| US2012/0078140(A1) | 2012-03-01 | Nita | Applicant |
| US2012/0078285(A1) | 2012-03-01 | Griffin | Applicant |
| US2012/0089216(A1) | 2012-04-01 | Rapaport et al. | Applicant |
| US2012/0116443(A1) | 2012-05-01 | Ferrera et al. | Applicant |
| EP321912 | 1989-06-01 | Applicant | |
| EP1000590 | 2000-05-01 | Applicant | |
| EP1437097 | 2004-07-01 | Applicant | |
| EP2257248(B1) | 2011-10-01 | Applicant | |
| EP2301450(B1) | 2011-11-01 | Applicant | |
| EP2417919(A2) | 2012-02-01 | Applicant | |
| JP2006-094876 | 2006-04-01 | Applicant | |
| WO-94/03127(A1) | 1994-02-01 | Applicant | |
| WO98/55173 | 1998-12-01 | Applicant | |
| WO/32265 | 2000-06-01 | Applicant | |
| WO/53120 | 2000-09-01 | Applicant | |
| WO-01/08743 | 2001-02-01 | Applicant | |
| WO1/36034 | 2001-05-01 | Applicant | |
| WO1/45569 | 2001-06-01 | Applicant | |
| WO3/011188 | 2003-02-01 | Applicant | |
| WO3/017823 | 2003-03-01 | Applicant | |
| WO2007/089897 | 2007-08-01 | Applicant | |
| WO2007/121005 | 2007-10-01 | Applicant | |
| WO2008/117256(A2) | 2008-10-01 | Applicant | |
| WO2008/117257(A2) | 2008-10-01 | Applicant | |
| WO-2008/124728 | 2008-10-01 | Applicant | |
| WO2009/105710 | 2009-08-01 | Applicant | |
| WO2009/124288 | 2009-10-01 | Applicant | |
| WO2009/126747 | 2009-10-01 | Applicant | |
| WO2010/010545 | 2010-01-01 | Applicant | |
| WO2010/023671 | 2010-03-01 | Applicant | |
| WO2010/046897 | 2010-04-01 | Applicant | |
| WO2010/049121 | 2010-05-01 | Applicant | |
| WO2010/062363 | 2010-06-01 | Applicant | |
| WO2010/102307 | 2010-09-01 | Applicant | |
| WO2010/115642 | 2010-10-01 | Applicant | |
| WO-2010/121037 | 2010-10-01 | Applicant | |
| WO-2010/121049(A9) | 2010-12-01 | Applicant | |
| WO-2011/054531(A3) | 2011-07-01 | Applicant | |
| WO-2011/095352 | 2011-08-01 | Applicant | |
| WO-2011/133486 | 2011-10-01 | Applicant | |
| WO-2011/135556 | 2011-11-01 | Applicant | |
| WO-2011/144336 | 2011-11-01 | Applicant | |
| WO-2011/147567 | 2011-12-01 | Applicant | |
| WO-2012/009675(A2) | 2012-01-01 | Applicant | |
| WO-2012/025245 | 2012-03-01 | Applicant | |
| WO-2012/025247 | 2012-03-01 | Applicant |
Non-Patent Literature (16)
- US 5,485,450, 8/1998, Mische et al. (withdrawn).Applicant
- T.W. Duerig, D.E. Tolomeo, M. Wholey, An Overview of Superelastic Stent Design.Applicant
- Michael E. Kelly, MD, et al., Recanalization of an Acute Middle Cerebral Artery Occlusion Using a Self-Expanding, Reconstrainable, Intracranial Microstent as a Temporary Endovascular Bypass; Stroke, Jun. 2008, pp. 1770-1773, vol. 39, issue 6, United States.Applicant
- Eric Sauvegeau, MD et al., Middle Cerebral Artery Stenting for Acute Ischemic Stroke After Unsuccessful Merci Retrieval; Neurosurgery (Special Technical Report), Apr. 2007, pp. 701-706, vol. 60, issue 4, United States.Applicant
- David M. Pelz, et al., Advances in Interventional Neuroradiology 2007; Stroke, Jan. 2008, pp. 268-272, vol. 39, issue 1, United States.Applicant
- Philippa C. Lavallee, et al., Stent-Assisted Endovascular Thrombolysis Versus Intravenous Thrombolysis in Internal Carotid Artery Dissection with Tandem Internal Carotid and Middle Cerebral Artery Occlusion; Stroke, Aug. 2007, pp. 2270-2274, vol. 38, issue 8, United States.Applicant
- E.I. Levy et al., Self-Expanding Stents for Recanalization of Acute Cerebrovascular Occlusions; AJNR, May 2007, pp. 816-822, vol. 28, United States.Applicant
- Micro Therapeutics, Inc., DBA EV3 Neurovascular, Inc., Solitaire FR Revascularization Device, Instructions for Use, 70494-001 Rev. Mar. 2009.Applicant
- Micro Therapeutics, Inc., DBA EV3 Neurovascular, Inc., Fully depolyable. Completely retrievable. Solitaire AB, Neurovascular Remodeling Device.Applicant
- Robertson, Kathy, Stroke device startup lands National Science Foundation grant, Sacramento Business Journal, Oct. 23, 2009, Sacramento, California, USA.Applicant
- Henkes, H. et al., “A Microcatheter-Delivered Highly-Flexible and Fully-Retrievable Stent, Specifically Designed for Intracranial Use,” Interventional Neuroradiology, vol. 9, pp. 391-393 (Dec. 2003).Applicant
- Doerfler, A. et al., “A Novel Flexible, Retrievable Endovascular Stent System for Small-Vessel Anatomy: Preliminary In Vivo Data,” Am. J. Neuroradiol. vol. 26, pp. 862-868 (Apr. 2005).Applicant
- Liebig, T. et al., “A novel self-expanding fully retrievable intracranial stent (SOLO): experience in nine procedures of stent-assisted aneurysm coil occlusion,” Neuroradiology vol. 48, pp. 471-478 (Jul. 2006).Applicant
- Yavuz, K. et al., “Immediate and midterm follow-up results of using an electrodetachable, fully retrievable SOLO stent system in the endovascular coil occlusion of wide-necked cerebral aneurysms,” J. Neurosurg. vol. 107, pp. 49-55 (Jul. 2007).Applicant
- “Penumbra, Inc. Enrolls First Patients in PULSE Clinical Trial to Evaluate a Fully Retrievable, Dense Mesh Temporary Stent for Immediate Flow Restoration in Interventional Acute Ischemic Stroke Treatment,” Business Wire, Nov. 1, 2010, downloaded at http://www.businesswire.com/news/home/20101101006991/en/Penumbra-Enrolls-Patients-PULSE-Clinical-Trial-Evaluate.Applicant
- Wakhloo, et al., “Retrievable Closed Cell Intracranial Stent for Foreign Body and Clot Removal,” Neurosurgery, May 2008.Applicant